CN Stock MarketDetailed Quotes

Hubei Hongyuan Pharmaceutical Technology (301246)

Watchlist
  • 29.97
  • +4.08+15.76%
Market Closed Apr 30 15:00 CST
11.99BMarket Cap47.12P/E (TTM)

Hubei Hongyuan Pharmaceutical Technology (301246) Revenue Breakdown Overview

By Product

Currency:CNY
2025/FY
Stock NameRevenueRatio
API and pharmaceutical intermediates917.25M47.29%
Lithium battery material674.3M34.77%
Organic chemical raw materials208.76M10.76%
Pharmaceutical preparation89.64M4.62%
Other49.53M2.55%

By Industry

Currency:CNY
2025/FY
Stock NameRevenueRatio
Pharmaceutical manufacturing industry1.01B51.92%
Chemical raw materials and chemical products manufacturing883.05M45.53%
Other49.53M2.55%

By Country/Region

Currency:CNY
2025/FY
Stock NameRevenueRatio
Territory1.58B81.69%
Overseas355.07M18.31%

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights
Middle East conflict spreads to the stock market! How should investors respond?
Iran has announced its latest negotiation proposal: all issues should be resolved within 30 days, with the focus placed on 'ending the war' Show More